Formation of Lymphoma Hybrid Spheroids and Drug Testing in Real Time with the Use of Fluorescence Optical Tweezers

Cells. 2022 Jul 5;11(13):2113. doi: 10.3390/cells11132113.

Abstract

Interactions between stromal and lymphoma cells in the bone marrow are closely related to drug resistance and therapy failure. Physiologically relevant pre-clinical three-dimensional (3D) models recapitulating lymphoma microenvironmental complexity do not currently exist. In this study, we proposed a scheme for optically controlled hybrid lymphoma spheroid formation with the use of optical tweezers (OT). Following the preparation of stromal spheroids using agarose hydrogel, two aggressive non-Hodgkin lymphoma B-cell lines, Ri-1 (DLBCL) and Raji (Burkitt lymphoma), were used to conduct multi-cellular spheroid formation driven by in-house-developed fluorescence optical tweezers. Importantly, the newly formed hybrid spheroid preserved the 3D architecture for the next 24 h. Our model was successfully used for the evaluation of the influence of the anticancer agents doxorubicin (DOX), ibrutinib (IBR), and AMD3100 (plerixafor) on the adhesive properties of lymphoma cells. Importantly, our study revealed that a co-treatment of DOX and IBR with AMD3100 affects the adhesion of B-NHL lymphoma cells.

Keywords: 3D lymphoma model; AMD3100 (plerixafor); cell adhesion; cell co-culture; doxorubicin (DOX); ibrutinib (IBR); lymphoma–stromal cell crosstalk; optical tweezers; single-cell manipulations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Doxorubicin / pharmacology
  • Hematopoietic Stem Cell Mobilization
  • Heterocyclic Compounds*
  • Humans
  • Lymphoma, B-Cell*
  • Lymphoma, Non-Hodgkin* / drug therapy
  • Optical Tweezers
  • Spheroids, Cellular

Substances

  • Heterocyclic Compounds
  • Doxorubicin

Grants and funding

This work is financially supported by The National Science Centre, Poland (NCN, Poland); OPUS. UMO-2017/27/B/ST7/01255.